Clinical Trials · NCT01536665
The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 45
- Start date
- Feb 2012
- Locations
- 1 site, Austria
- Primary endpoint
- Geometric mean glucagon concentration during hypoglycaemia (nadir glucose (target 2.5 mmol/L) )